PRO-02

N/A

Report date: 2022/09/09 14:09:24

Base Information

Drug NamePRO-02
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionAnti-Complement C2
TargetsComplement C2
Therapy Area/IndicationsRejection of renal transplantationReperfusion InjuryRejection of liver transplantation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesProthix BV
China Registration ClassN/A

Develop Information

Active CompaniesProthix BV
Inactive CompaniesN/A
Active IndicationsRejection of renal transplantationReperfusion InjuryRejection of liver transplantation
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A